Macrophage polarization and its role in liver disease

C Wang, C Ma, L Gong, Y Guo, K Fu, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Macrophages are important immune cells in innate immunity, and have remarkable
heterogeneity and polarization. Under pathological conditions, in addition to the resident …

Microbiota and fatty liver disease—the known, the unknown, and the future

S Lang, B Schnabl - Cell host & microbe, 2020 - cell.com
The liver communicates with the intestine via the portal vein, biliary system, and mediators in
the circulation. Microbes in the intestine maintain liver homeostasis but can also serve as a …

MAFLD and risk of CKD

DQ Sun, Y **, TY Wang, KI Zheng, RS Rios, HY Zhang… - Metabolism, 2021 - Elsevier
Background/aims Whereas nonalcoholic fatty liver disease (NAFLD) is a multisystem
disease, the association between metabolic dysfunction-associated fatty liver disease …

Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications

TH Gao, W Liao, LT Lin, ZP Zhu, MG Lu, CM Fu, T **e - Phytomedicine, 2022 - Elsevier
Background Hepatobiliary disease currently serves as an urgent health issue in public due
to health-modulating factors such as extension of life expectancy, increasingly sedentary …

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

X Niu, L Zhu, Y Xu, M Zhang, Y Hao, L Ma, Y Li… - BMC Public Health, 2023 - Springer
Background Alcohol related liver disease (ARLD) is one of the major chronic liver diseases
worldwide. This review aimed to describe the global prevalence, incidence, and outcomes of …

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease

Y Nan, J An, J Bao, H Chen, Y Chen, H Ding, X Dou… - Journal of …, 2021 - Elsevier
Fatty liver disease associated with metabolic dysfunction is of increasing concern in
mainland China, the world's most populous country. The incidence of fatty liver disease is …

[HTML][HTML] Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis

Q Wang, H Zhao, Y Deng, H Zheng, H **ang, Y Nan… - Journal of …, 2022 - Elsevier
Background & Aims Antiviral therapy improves the clinical outcomes of patients with chronic
hepatitis B (CHB), including those with cirrhosis. In the present study, we validated the …

Delivery strategy to enhance the therapeutic efficacy of Liver Fibrosis via Nanoparticle Drug Delivery systems

J Liu, J Liu, W Mu, Q Ma, X Zhai, B **, Y Liu, N Zhang - ACS nano, 2024 - ACS Publications
Liver fibrosis (LF) is a pathological repair reaction caused by a chronic liver injury that affects
the health of millions of people worldwide, progressing to life-threatening cirrhosis and liver …

Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy

LF Zhang, XH Wang, CL Zhang, J Lee, BW Duan… - ACS …, 2022 - ACS Publications
During liver fibrogenesis, liver sinusoidal capillarization and extracellular matrix (ECM)
deposition construct dual pathological barriers to drug delivery. Upon capillarization, the …

Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors

T Yin, Y Li, Y Ying, Z Luo - BMC infectious diseases, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is an infectious disease
characterized by cough, fever, and fatigue and 20% of cases will develop into severe …